Director, IT Business Partner Commercial (Pharmaceutical)

Location: Woburn, United States; hybrid work with onsite attendance at least 2 days per week for local candidates

Salary: $208,000–$270,000 annual base pay

Company

hirify.global is a biotechnology company developing oncolytic immunotherapies to transform cancer treatment.

What you will do

• Lead the configuration, maintenance, and ongoing operations of commercial CRM systems, primarily Veeva and Salesforce.
• Integrate marketing tools and platforms with CRM systems to improve marketing automation and customer engagement.
• Manage commercial technology needs, software deployments, projects, and third-party support providers.
• Collaborate with marketing, sales, market access, medical, and IT teams across commercial platforms and channels.
• Manage Oracle data warehouse capabilities, master data management, analytics, and technology supporting field staff.
• Oversee commercial websites and ensure compliance with data handling and privacy requirements in life sciences and healthcare.

Requirements

• Bachelor’s degree in computer science, information technology, business administration, or a related field, or equivalent practical experience.
• 10+ years of relevant professional experience.
• Commercial pharmaceutical industry experience.
• Strong technical proficiency in Salesforce, Veeva, and Oracle architecture, configuration, and customization.
• Knowledge of SQL, JavaScript, or Apex, along with strong analytical, problem-solving, leadership, and team management skills.
• Experience with project management tools such as JIRA or MS Project and marketing platforms such as Salesforce Marketing Cloud or Adobe Experience Manager.

Nice to have

• Salesforce, Veeva, or Oracle certifications.

Culture & Benefits

• Purpose-driven work focused on improving cancer treatment and patient outcomes.
• Collaborative, bold, dedicated, and candid working environment.
• Medical, dental, and vision insurance.
• 401(k) matching, flexible time off, and paid holidays including a year-end shutdown.
• Annual performance incentive bonus and performance-based equity opportunities.